– New US president, new Brexit deal, new vaccine hope – will 2021 be a shot in the arm for investors?
– Linden Thomson, manager of the Axa Framlington Biotech fund, on the role of vaccine makers
– Courtiers’ Caroline Shaw warns people shun value investing at their peril
– Quilter CEO Paul Feeney on M&A, a thriving workplace and the death of diversification
January 2021
– New US president, new Brexit deal, new vaccine hope – will 2021 be a shot in the arm for investors? – Linden Thomson, manager of the Axa Framlington Biotech fund, on the role of vaccine makers – Courtiers’ Caroline Shaw warns people shun value investing at their peril – Quilter CEO Paul Feeney on…
